Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure.

Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure.
复制标题

DOI:
10.1038/s41598-018-23755-y
复制
发表时间:
2018-04-04
期刊:
影响因子:
4.6
通讯作者:
Higuchi K
Higuchi K
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Yang M;Liu Y;Dai J;Li L;Ding X;Xu Z;Mori M;Miyahara H;Sawashita J;Higuchi K

文献摘要

参考文献

相似文献

在急性时相反应(APR)期间,血清淀粉样蛋白A(SAA)在血浆高密度脂蛋白(HDL)中显著升高。在动物和人类中,SAA升高导致反应性AA淀粉样变性。在此,我们利用载脂蛋白A-II缺陷(ApoA-II)缺陷(ApoA_2−/−)和转基因(ApoA_2Tg)小鼠来研究ApoA-II在APR过程中脂蛋白颗粒形成和AA淀粉样变性进展中的潜在作用。与野生型(WT)小鼠相比,ApoA2−/−小鼠AA淀粉样蛋白沉积受到抑制。在APR期间,APOA2−/−小鼠的血清SAA水平和肝脏SAA1和SAA2基因水平均受到显著抑制。病理检查显示,APOA2−/−小鼠在APR过程中组织损伤较轻,炎性细胞浸润较少。ApoA2−/−组小鼠总脂蛋白显著降低,高密度脂蛋白/低密度脂蛋白比值也明显降低。WT和APOA2−/−小鼠在APR期间都表现出低密度脂蛋白和非常大的高密度脂蛋白的升高。在apoA2−/−小鼠中,SAA在从乳糜粒到非常小的高密度脂蛋白的脂蛋白颗粒中分布更广泛。我们的观察揭示了ApoA-II在炎症、血清脂蛋白稳定性和AA淀粉样变性发病率中的关键作用,并促使人们考虑治疗AA和其他淀粉样变性,其前体蛋白与循环中的高密度脂蛋白颗粒相关。
During acute-phase response (APR), there is a dramatic increase in serum amyloid A (SAA) in plasma high density lipoproteins (HDL). Elevated SAA leads to reactive AA amyloidosis in animals and humans. Herein, we employed apolipoprotein A-II (ApoA-II) deficient (Apoa2−/−) and transgenic (Apoa2Tg) mice to investigate the potential roles of ApoA-II in lipoprotein particle formation and progression of AA amyloidosis during APR. AA amyloid deposition was suppressed in Apoa2−/− mice compared with wild type (WT) mice. During APR, Apoa2−/− mice exhibited significant suppression of serum SAA levels and hepatic Saa1 and Saa2 mRNA levels. Pathological investigation showed Apoa2−/− mice had less tissue damage and less inflammatory cell infiltration during APR. Total lipoproteins were markedly decreased in Apoa2−/− mice, while the ratio of HDL to low density lipoprotein (LDL) was also decreased. Both WT and Apoa2−/− mice showed increases in LDL and very large HDL during APR. SAA was distributed more widely in lipoprotein particles ranging from chylomicrons to very small HDL in Apoa2−/− mice. Our observations uncovered the critical roles of ApoA-II in inflammation, serum lipoprotein stability and AA amyloidosis morbidity, and prompt consideration of therapies for AA and other amyloidoses, whose precursor proteins are associated with circulating HDL particles.
DOI: 10.1016/j.clnu.2010.04.006
发表时间: 2010-12-01
期刊: CLINICAL NUTRITION
影响因子: 6.3
作者:
Saka, Bulent;Kaya, Omer;Karan, M. Akif
通讯作者: Karan, M. Akif
DOI: 10.1016/j.clnu.2016.07.014
发表时间: 2017-08-01
期刊: CLINICAL NUTRITION
影响因子: 6.3
作者:
Poulia, Kalliopi-Anna;Klek, Stanislaw;Chourdakis, Michael
通讯作者: Chourdakis, Michael
DOI: 10.1016/j.jamda.2017.07.006
发表时间: 2018-01-01
影响因子: 7.6
作者:
Kim, Sunyoung;Kim, Miji;Won, Chang Won
通讯作者: Won, Chang Won
DOI: 10.1016/j.clnu.2016.11.018
发表时间: 2018-02-01
期刊: CLINICAL NUTRITION
影响因子: 6.3
作者:
Rondel, A. L. M. A.;Langius, J. A. E.;Kruizenga, H. M.
通讯作者: Kruizenga, H. M.
DOI: 10.1016/j.eurger.2015.12.002
发表时间: 2016-06-01
影响因子: 3.8
作者:
Bruyere, O.;Beaudart, C.;Reginster, J. -Y.
通讯作者: Reginster, J. -Y.